drugset / Trial / NCT01585246

Saw Palmetto: Symptom Management for Men During Radiation Therapy

NCT01585246 ↗

Phase 1/2 Completed 48 enrolled Michigan State University
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to test whether Saw Palmetto, is useful in preventing or reducing the side effects for men undergoing radiation therapy for prostate cancer. Urinary symptoms will be recorded each week, as well as assessment of quality of life through: 1) Physical Well-Being 2) Social/Family Well-being 3) Emotional Well-Being, and 4) Functional Well-Being.

Timeline

Start
2011-10
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Saw Palmetto Unknown 320 mg —
Subject Saw Palmetto Unknown 640 mg —
Subject Saw Palmetto Unknown 960 mg —

Indications